RIVER: Rivaroxaban Rivals Warfarin in AF, Mitral Bioprosthesis RIVER: Rivaroxaban Rivals Warfarin in AF, Mitral Bioprosthesis

The trial from Brazil may not be easily extrapolated to other regions, but it starts to fill a largely vacant evidence base for patients not well represented in major trials of nonvalvular AF DOACs.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news